In this episode, Amy and Nikki discuss the impact of proton pump inhibitors (PPIs) on gut health, specifically focusing on their relation to the development of irritable bowel syndrome (IBS). They cover what PPIs are, common brands, and why they are prescribed. The conversation highlights the controversy surrounding PPIs, noting that while they can be necessary for certain conditions like gastritis and esophagitis, they are often overprescribed or used inappropriately, leading to various health risks.
They emphasize the importance of gradual tapering off PPIs to avoid rebound reflux and discuss the potential for PPIs to cause dysbiosis in the small intestine. They also mention strategies for mitigating the negative effects of PPIs, such as probiotics and prokinetics, and underline the importance of balancing the benefits and risks of these medications.
00:00 Welcome Back and New Year Greetings 00:19 Introduction to PPIs 02:23 Controversies and Risks of PPIs 03:32 PPIs and IBS Connection 05:29 Proper Use and Tapering Off PPIs 09:49 Prevalence and Impact of PPI Use 11:38 Understanding Stomach Acid and Microbiome 15:37 Microbiology and Real-World Applications 19:09 Understanding Stomach pH and PPIs 19:43 Impact of PPIs on the Microbiome 20:47 Studies Linking PPIs to IBS 25:14 Mitigation Strategies for PPI-Induced IBS 31:18 Realistic Expectations for Managing IBS and Autoimmunity 35:46 Concluding Thoughts and Future Topics
Love this episode? Be sure to LIKE it and SUBSCRIBE :)
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr. Nicole DiNezza, DC, NTP and Amy Hollenkamp, RD. Innehållet i podden är skapat av Dr. Nicole DiNezza, DC, NTP and Amy Hollenkamp, RD och inte av,
eller tillsammans med, Poddtoppen.